Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Update

Lonza Group Ag (OTCMKTS:LZAGY) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totaling 27,701 shares, a growth of 393.0% from the December 31st total of 5,619 shares. Based on an average trading volume of 75,219 shares, the short-interest ratio is currently 0.4 days. Currently, 0.0% of the shares of the company are sold short. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 75,219 shares, the short-interest ratio is currently 0.4 days.

Lonza Group Price Performance

Shares of OTCMKTS:LZAGY opened at $72.76 on Wednesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.87 and a current ratio of 1.46. Lonza Group has a 52-week low of $55.57 and a 52-week high of $73.85. The business has a 50-day moving average price of $67.97 and a 200-day moving average price of $68.77.

About Lonza Group

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.